North America Research Institute

What North America Research Institute does

North America Research Institute (NARI) is a privately held Site Management Organization headquartered in San Dimas, California, that conducts Phase I through IV clinical trials for pharmaceutical, biotechnology, and medical device sponsors. The company is physician-owned and operates through a network of 18+ board-certified physician investigators and 15+ affiliated dialysis centers and medical practices across Southern California, giving sponsors access to specialty patient populations — particularly in nephrology, endocrinology, infectious disease, and adjacent therapeutic areas. NARI is currently enrolling in trials across conditions including Membranous Nephropathy, Diabetic Nephropathy, FSGS, Hyperkalemia, IgA Nephropathy, Metabolic Acidosis, Resistant Hypertension, and Type 2 Diabetes.

NARI's core offering consists of three integrated service lines: Sponsor Services (expedited CDA, site feasibility, regulatory, budget and contract review, study drug and CRF storage, data management, and quality assurance), Patient Services (in-house EKG/ABPM, Echo Doppler, MRI radiology, transportation support, and compassionate care at multiple locations), and active study enrollment in therapeutic areas where it claims specific recruitment expertise. The company has stated it carries out Phase I-IV drug and device trials for over 12 years and has more than 15 years of combined investigator experience. Infrastructure is centered on a centralized administrative office and a Southern California affiliate network rather than proprietary technology.

NARI generates revenue through professional services fees negotiated with pharmaceutical sponsors on a per-study basis; pricing is not publicly disclosed. Its go-to-market combines direct enterprise field sales to pharma/CRO sponsors with inside-sales-style patient recruitment via phone outreach and online registration forms. The customer base comprises 19 named enterprise pharmaceutical sponsors (including Amgen, Pfizer, Merck, Novartis, Roche, GSK, AstraZeneca, Eli Lilly, Sanofi, Gilead, Bayer, Novo Nordisk, Janssen, and others), with no disclosed SMB or long-tail customer segment. Operations are confined to Southern California, with two main offices in San Dimas and Lynwood and a broader affiliated network of nephrology practices and dialysis centers.

Name

North America Research Institute

Legal name

North America Research Institute

Website

https://nariresearch.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

North America Research Institute is a physician-owned Site Management Organization in Southern California that runs Phase I-IV clinical trials for pharmaceutical, biotech, and medical device sponsors, leveraging a network of 18+ investigators and 15+ affiliated dialysis centers.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Site Management Organization)

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAA

Site Network Operators & SMOs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAB

Site Identification & Feasibility

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAC

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

Keywords

• Clinical trial services
• Site management organization
• Clinical research services
• Patient recruitment services
• Clinical study conduct

Headquarters

HQ city

San Dimas

HQ country

United States

HQ region

North America

Offices21 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Clinical Trial Services for Sponsors: Revenue generated from conducting clinical trials for pharmaceutical, biotechnology, and medical device companies. Services include site management, patient recruitment, data collection, quality assurance, and regulatory compliance support for Phase I-IV studies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

NARI operates as a Site Management Organization (SMO) conducting Phase I, II, III, and IV clinical trials for pharmaceutical, biotechnology, and medical device sponsors. Services cover site management, patient recruitment, regulatory and budget support, study drug and CRF storage, quality assurance, and trial execution across an affiliated network of dialysis centers and medical practices in Southern California. The organization also provides in-house diagnostic facilities (EKG, ABPM, Echo Doppler, MRI) and patient-facing support such as transportation assistance.

Product overview

North America Research Institute (NARI) operates as a Site Management Organization (SMO) providing a unified platform for clinical trial conduct. The core offering consists of comprehensive clinical trial services encompassing Phase I through IV trials for pharmaceutical, biotechnology, and medical device sponsors. The portfolio includes Sponsor Services (regulatory support, budget negotiation, study drug management, data management), Patient Services (medical care, transportation, radiology facilities), and Current Clinical Studies across multiple therapeutic areas including nephrology, endocrinology, infectious diseases, and cardiovascular conditions. With over 12 years of experience, NARI leverages an affiliated network of dialysis centers and physician investigators to deliver clinical research across Southern California.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Services Phase I, II, III, and IV clinical trial conduct for pharmaceutical, biotechnology, and medical device sponsors, delivered through a Site Management Organization model in Southern California. Includes site management, regulatory compliance, data management, and quality assurance for multiple therapeutic areas (nephrology, endocrinology, infectious diseases, family practice).
• Sponsor Services Comprehensive services for pharmaceutical and biotech sponsors including study drug room storage, CRF storage, regulatory support, budget negotiation, site identification, CDA, feasibility, contract review, and quality assurance, enabled by a centralized research administrative office.
• Patient Services Patient-facing clinical trial services including professional medical staff, compassionate care, exam rooms at multiple Southern California locations, in-house EKG and ABPM, transportation services, and access to Echo Doppler and MRI radiology facilities.
• Clinical Research Experiences Over 12 years of experience conducting Phase 1-IV drug and device trials across therapeutic areas including Chronic Kidney Disease, End Stage Renal Disease, diabetes, hypertension, infectious diseases, family practice, and oncology, with more than 15 years of combined staff experience.
• Current Clinical Studies Active enrollment in clinical trials for Anti-PLA2R antibody positive Membranous Nephropathy, Diabetic Nephropathy, Focal Segmental Glomerulosclerosis (FSGS), Hyperkalemia, IgA Nephropathy, Metabolic Acidosis, Proteinuria, Recurrent C-Diff Infections, Resistant Hypertension, and Type 2 Diabetes.

Quantifiable outcome

• Exceeding enrollment goals through streamlined screening and enrollment policies and procedures
• +2 more outcomes

Named customers19 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

23 partnerships are on record, tiered core.

• AmgencoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services including Phase I-IV drug trials.
• BayercoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services for various therapeutic areas.
• GSKcoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has conducted clinical trials for GSK products.
• Merck & Co., Inc.coreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. Major pharmaceutical company utilizing NARI's site management services.
• Gilead Sciences, Inc.coreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has conducted clinical trials for Gilead products.
• Novartis Pharmaceutical Corp.coreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services.
• Roche LaboratoriescoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has conducted clinical trials for Roche products.
• PfizercoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. Major pharmaceutical company utilizing NARI's site management organization services.
• OtsukacoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has conducted clinical trials for Otsuka products.
• FibroGen Inc.coreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services.
• Novo NordiskcoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has conducted clinical trials for Novo Nordisk products.
• AkebiacoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services.
• AstraZenecacoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has conducted clinical trials for AstraZeneca products.
• SanoficoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. Major pharmaceutical company utilizing NARI's services.
• AlnylamcoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services.
• Boehringer IngelheimcoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has conducted clinical trials.
• Janssen Research & DevelopmentcoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services.
• Eli LillycoreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. Major pharmaceutical company utilizing NARI's services.
• Abbott Laboratories/Paragon Biomedical, Inc.coreStrategic or Co-development PartnerPharmaceutical sponsor for clinical trial services. NARI has provided clinical trial services.
• California Kidney SpecialistscoreStrategic or Co-development PartnerAffiliated medical practice providing nephrology services at San Dimas and Covina locations. Partner practice for clinical trial patient referrals.
• Renal Medical AssociatescoreStrategic or Co-development PartnerAffiliated nephrology practice. Partner practice for clinical trial patient referrals and trial conduct.
• Riverside Nephrology PhysicianscoreStrategic or Co-development PartnerAffiliated nephrology practice in Riverside. Partner for clinical trial conduct and patient referrals.
• DaVitacoreStrategic or Co-development PartnerMajor dialysis provider with multiple affiliated centers (Imperial Care, Kidney Dialysis Care Unit, Premier, United). Partner providing access to dialysis patient populations for clinical trials.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Medpace: Mid-to-large full-service CRO with a global site network and strong therapeutic-area expertise. Comparable to NARI as a sponsor-facing clinical trial operator and competes for the same study awards, with a heavier therapeutic mix in oncology and cardiometabolic disease that overlaps with NARI's focus areas.
• Syneos Health: Large global CRO with site management and patient recruitment capabilities, serving biopharmaceutical sponsors across therapeutic areas including nephrology. Comparable to NARI as a sponsor-facing site manager, but with broader therapeutic reach and a multi-region site footprint.
• ICON plc: Global CRO and site-management provider formed through multiple acquisitions, including PRA Health Sciences. Competes with NARI for the same sponsor study-award decisions and provides full-service site management across Phase I-IV trials, though at much larger scale and broader therapeutic and geographic scope.
• IQVIA: The world's largest CRO, with a global site network and dedicated site management organization (IQVIA Site Solutions). Overlaps with NARI on the SMO/site-management side of the clinical trial value chain, serving the same pharma sponsors but at vastly larger scale and with multi-region capabilities NARI lacks.
• Worldwide Clinical Trials: Mid-sized global CRO with strong therapeutic-area focus in cardiometabolic, CNS, and rare disease, including significant nephrology trial experience. Comparable to NARI on the sponsor-relationship and trial-execution dimensions, with a broader therapeutic portfolio and multi-region capabilities.
• PPD (Thermo Fisher Scientific): Global CRO and clinical research services provider, now part of Thermo Fisher Scientific, with site management and patient recruitment offerings. Competes with NARI on the sponsor side for multi-site trial awards, with substantially larger scale, technology infrastructure, and geographic reach.

Direct peers

• Clinipace Worldwide: Mid-sized CRO with therapeutic-area expertise and site management capabilities serving small-to-mid-sized biopharma sponsors. Comparable to NARI on the mid-market sponsor relationship and therapeutic specialty dimensions, though with a different geographic and therapeutic mix.
• Frenova Renal Research: Fresenius Medical Care's dedicated renal-focused clinical research arm, operating as a specialized SMO for kidney disease and dialysis-patient trials. Directly comparable to NARI because both are specialty SMOs centered on nephrology/CKD trial conduct, with deeply embedded access to dialysis patient populations.
• WCCT Global: Specialty clinical research site network operating as a multi-therapeutic SMO with a database of trial-ready patients. Comparable to NARI as a smaller, dedicated SMO competing for sponsor trial volume, with a similar scale tier and focus on operational efficiency rather than global scale.
• DaVita Clinical Research: DaVita's dedicated clinical research division, leveraging DaVita's dialysis center footprint to run renal and adjacent therapeutic trials. Highly comparable to NARI: same nephrology-specialty SMO model, same patient access via affiliated dialysis centers, and an active overlap in the same pool of CKD/ESRD sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/north-america-research-institute

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about North America Research Institute